Pharmacotherapy for PTSD
First-Line Treatment
- The American Academy of Sleep Medicine recommends SSRIs as the established first-line pharmacological treatment for PTSD, with sertraline and paroxetine holding FDA approval for this indication 1
- Response rates with SSRIs reach 53-85% in clinical trials, significantly outperforming placebo (32-62%) 1
SNRIs as Second-Line Treatment
- SNRIs have demonstrated efficacy in other anxiety disorders and chronic pain conditions, which provides indirect support for their use in PTSD 2
- In anxiety disorders more broadly, SNRIs show comparable efficacy to SSRIs with similar response rates and dropout rates, according to the American College of Neuropsychopharmacology 3
Treatment Algorithm for PTSD Pharmacotherapy
- For partial responders, consider adding atypical antipsychotics (risperidone has strongest evidence) or prazosin for nightmares, as recommended by the American Academy of Sleep Medicine 4
Critical Safety Considerations for SNRIs
- Monitor blood pressure and pulse regularly, as SNRIs are associated with sustained hypertension and increased pulse, according to the American College of Cardiology 3
- Never discontinue SNRIs abruptly—require slow taper due to significant discontinuation syndrome, particularly with venlafaxine, as recommended by the American Psychiatric Association 3
Duration of Treatment
- Relapse rates are higher with medication discontinuation (26-52% for sertraline) compared to completion of cognitive behavioral therapy, according to the American Psychological Association 1